Proteus Syndrome

Proteus Syndrome is a rare genetic condition that causes unusual growth in parts of the body. It can make hands and feet grow much larger than normal, and it can also cause bumps or growths like hemangiomas or lipomas. It's not contagious and affects only a small number of people.

Condition

What people with Proteus Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you had Orthopedic Procedures for Proteus Syndrome?

NameHow it went

About Proteus Syndrome

What It Is

Proteus syndrome is a very rare genetic condition in which parts of the body grow too much. Bones, skin, fat, blood vessels and sometimes organs grow out of proportion to the rest of the body, and the overgrowth usually affects the two sides unevenly. One leg may become longer than the other, or a single hand or foot may grow much larger. Fewer than one in a million people are thought to have it. Most babies with Proteus syndrome look typical or nearly so at birth. Overgrowth usually becomes noticeable between about 6 and 18 months of age and then progresses through childhood, sometimes quickly. Common features include overgrowth of the limbs, skull and spine, patches of excess fat, and a thick, deeply grooved skin growth on the soles of the feet called a cerebriform connective tissue nevus, which is rarely seen in any other condition. The pattern differs greatly from person to person. The condition matters beyond appearance because it can affect movement, breathing and blood clotting. Joseph Merrick, known as the Elephant Man, is now thought to have had Proteus syndrome rather than neurofibromatosis, the condition once blamed. Several other overgrowth conditions can look similar, which is why an accurate diagnosis is important.

Causes & Risk Factors

Proteus syndrome is caused by a change in a gene called AKT1, which helps control how cells grow and divide. The change is not inherited. It happens by chance in a single cell early in development before birth, so only the cells descended from that one carry it. This mix of affected and unaffected cells is called mosaicism, and it explains why overgrowth appears in some body parts and not others. Nothing a parent did before or during pregnancy causes the condition, and it does not run in families. No case has been confirmed in a brother, sister or child of an affected person, although very few affected adults have had children. A separate condition sometimes called Proteus-like syndrome is caused by changes in a different gene, PTEN. It belongs to a group called PTEN hamartoma tumor syndrome, which can be inherited and carries its own cancer risks, so the distinction affects family testing and long-term screening.

How It's Diagnosed

Diagnosis usually involves a genetics specialist. Doctors use published criteria that look for three general features: overgrowth in a patchy or one-sided pattern, no family history, and a course that worsens over time. They then score specific findings, such as the grooved nevus on the feet, uneven limb overgrowth and particular fat or blood vessel changes. A higher score is needed when genetic testing does not confirm the AKT1 change. People with the AKT1 change but only a few features may be described as having AKT1-related overgrowth spectrum. Genetic testing is usually done on a small sample (biopsy) of affected tissue, most often skin, because the AKT1 change is typically not detectable in a blood sample. A negative blood test therefore does not rule the condition out. X-rays, CT scans and MRI help map bone, fat, brain and lung involvement, and ultrasound can check for masses or blood clots. The evaluation also considers look-alike conditions, including PIK3CA-related overgrowth conditions such as Klippel-Trenaunay syndrome, PTEN-related conditions and neurofibromatosis, since their causes and care differ.

Treatment Options

There is no approved medicine for Proteus syndrome, and treatment aims to limit the effects of overgrowth, protect function and prevent complications. Care is usually coordinated by a team that may include genetics, orthopedics, dermatology, lung, vascular and developmental specialists. Orthopedic care is often central. Surgeons may slow or stop growth in an overgrowing bone by treating its growth plate (epiphysiodesis), correct a curved spine (scoliosis) or angled limbs, or remove excess tissue when it interferes with movement or comfort. The timing of these operations matters because overgrowth keeps progressing through childhood, and many people need more than one. Physical and occupational therapy, along with custom footwear or orthotics for overgrown feet, help keep people moving. Because surgery raises the already high risk of blood clots, the care team closely watches for clots around any operation and considers blood thinners to prevent them. Medicines that increase clotting risk are generally avoided, as are growth-promoting medicines such as anabolic steroids or growth hormone. Lung cysts, tumors and seizures are treated by the relevant specialists if they occur. Medicines that block the AKT pathway, such as the experimental drug miransertib, are being studied in clinical trials. A small study found it was tolerated, but whether it slows overgrowth or improves function is not yet known.

What to Expect

Proteus syndrome is lifelong, and its course is hard to predict for any one person. Overgrowth tends to be most active during childhood. Some people have mild, limited features, while others develop severe overgrowth that affects walking, hand use, joint movement and posture. Joints can become stiff or even fixed if bone overgrowth is extensive. Daily life often involves regular visits to several specialists, planned surgeries, therapy and adapted shoes or equipment. Many people have typical intelligence, but some have learning disability, seizures or vision problems, which add school and developmental support to the plan. The visible differences can bring social and emotional strain for children and families, and counseling is considered helpful for most. Follow-up includes watching for the condition's specific complications. Blood clots in the deep veins can travel to the lungs, a complication called pulmonary embolism that is a leading cause of death in people with Proteus syndrome. About one in five people in published reports developed a tumor, most often in the reproductive organs or brain coverings, usually benign and treated with surgery. Doctors check for tumors through history and physical exams rather than routine scans. Some people develop cysts in the lungs that gradually make breathing harder.

When to Seek Help

See a doctor, ideally a genetics specialist, if a young child develops overgrowth on one side or in one limb, or a thick, grooved skin growth on the sole of a foot. For someone already diagnosed, raise new lumps, increasing breathlessness with activity, worsening pain or loss of movement at routine visits, and mention the diagnosis to any doctor planning surgery or prescribing hormones. Contact the care team right away for new pain, swelling, warmth or redness in a leg or arm, which can signal a deep vein clot. Call 911 for sudden shortness of breath, chest pain, coughing up blood or fainting, since these can mean a clot has reached the lungs.

Questions to Ask Your Doctor

  1. 1.Does this pattern meet the criteria for Proteus syndrome, or could it be another overgrowth condition, and was tissue tested for AKT1?
  2. 2.Which areas of overgrowth are most likely to affect movement or breathing, and when should surgery be considered?
  3. 3.How will we lower the risk of blood clots, especially before and after any operation?
  4. 4.What checkups and which specialists should be part of regular follow-up?
  5. 5.Are there clinical trials, such as studies of AKT inhibitors, that might be suitable?

Last reviewed • Oct 2026

Educational content, not medical advice.